FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,253,000 | -14.9% | 300,000 | 0.0% | 0.18% | -7.9% |
| Q2 2023 | $2,649,000 | +6.1% | 300,000 | 0.0% | 0.19% | +2.2% |
| Q1 2023 | $2,496,000 | -13.3% | 300,000 | 0.0% | 0.19% | -23.8% |
| Q4 2022 | $2,880,000 | -7.6% | 300,000 | -22.0% | 0.24% | +1.2% |
| Q3 2022 | $3,117,000 | +31.4% | 384,824 | -9.5% | 0.24% | +43.5% |
| Q2 2022 | $2,373,000 | -12.5% | 425,338 | -12.2% | 0.17% | +15.9% |
| Q1 2022 | $2,712,000 | -13.1% | 484,318 | -31.7% | 0.14% | +26.1% |
| Q4 2021 | $3,121,000 | -70.2% | 709,300 | -36.1% | 0.12% | -71.8% |
| Q3 2021 | $10,456,000 | +29.2% | 1,110,000 | 0.0% | 0.41% | +45.7% |
| Q2 2021 | $8,091,000 | +17.4% | 1,110,000 | 0.0% | 0.28% | -23.3% |
| Q1 2021 | $6,894,000 | -16.6% | 1,110,000 | 0.0% | 0.36% | -6.6% |
| Q4 2020 | $8,269,000 | +22.9% | 1,110,000 | 0.0% | 0.39% | -20.7% |
| Q3 2020 | $6,727,000 | -27.4% | 1,110,000 | 0.0% | 0.49% | -33.6% |
| Q2 2020 | $9,269,000 | -17.9% | 1,110,000 | -41.6% | 0.74% | +11.7% |
| Q1 2020 | $11,288,000 | +83.1% | 1,900,000 | +100.0% | 0.66% | -5.8% |
| Q4 2019 | $6,165,000 | +32.0% | 950,000 | -2.2% | 0.70% | +35.8% |
| Q3 2019 | $4,672,000 | +20.3% | 971,351 | 0.0% | 0.52% | +47.0% |
| Q2 2019 | $3,885,000 | -17.5% | 971,351 | 0.0% | 0.35% | -17.3% |
| Q1 2019 | $4,711,000 | -24.0% | 971,351 | 0.0% | 0.43% | +13.6% |
| Q4 2018 | $6,197,000 | -22.2% | 971,351 | 0.0% | 0.38% | -27.3% |
| Q3 2018 | $7,965,000 | -12.0% | 971,351 | +12.0% | 0.52% | -15.5% |
| Q2 2018 | $9,053,000 | -13.7% | 867,185 | 0.0% | 0.61% | -34.0% |
| Q1 2018 | $10,489,000 | +20.7% | 867,185 | 0.0% | 0.93% | +26.6% |
| Q4 2017 | $8,689,000 | -2.0% | 867,185 | +7.3% | 0.73% | -21.5% |
| Q3 2017 | $8,867,000 | – | 808,365 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |